Maria Palasis, Lyra president and CEO
Facing empty reserves by year's end, Lyra is raising nearly double its 2020 IPO as it enters PhIII
Just weeks ago, Lyra Therapeutics thought it had enough cash to stay afloat only sometime into the final quarter of this year, but a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
